Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Strata Critical Medical (SRTA) EBIAT (2019 - 2025)

Historic EBIAT for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to $57.4 million.

  • Strata Critical Medical's EBIAT rose 112036.61% to $57.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.4 million, marking a year-over-year increase of 17326.04%. This contributed to the annual value of -$27.3 million for FY2024, which is 5130.36% up from last year.
  • According to the latest figures from Q3 2025, Strata Critical Medical's EBIAT is $57.4 million, which was up 112036.61% from -$3.7 million recorded in Q2 2025.
  • Strata Critical Medical's 5-year EBIAT high stood at $57.4 million for Q3 2025, and its period low was -$33.9 million during Q4 2023.
  • For the 5-year period, Strata Critical Medical's EBIAT averaged around -$5.9 million, with its median value being -$9.2 million (2021).
  • Its EBIAT has fluctuated over the past 5 years, first tumbled by 906978.68% in 2021, then surged by 112036.61% in 2025.
  • Quarter analysis of 5 years shows Strata Critical Medical's EBIAT stood at $772000.0 in 2021, then tumbled by 3631.09% to -$27.3 million in 2022, then fell by 24.51% to -$33.9 million in 2023, then surged by 71.15% to -$9.8 million in 2024, then skyrocketed by 686.3% to $57.4 million in 2025.
  • Its EBIAT stands at $57.4 million for Q3 2025, versus -$3.7 million for Q2 2025 and -$3.5 million for Q1 2025.